Amyotrophic Lateral Sclerosis (ALS)
Clinical Trials for Amyotrophic Lateral Sclerosis (ALS)
Thanks to funding from Proposition 71, California’s $3 billion investment in stem cell research, and the state funding entity it created, the California Institute for Regenerative Medicine (CIRM), there are now 36 human clinical trials in various stages of progress, including a trial for ...
Read More
Amyotrophic Lateral Sclerosis (ALS)
VIDEO: How Stem Cells Could Halt ALS
ALS is a fatal neurodegenerative disease that damages and destroys nerve cells in the brain and spinal cord. But with the support of CIRM, researchers are working to develop ways to slow or halt this disease.
Read More
Amyotrophic Lateral Sclerosis (ALS)
How can stem cells help treat amyotrophic lateral sclerosis (ALS, or Lou Gherig’s Disease)?
Neural stem cells can be engineered to secrete supportive molecules to the cells that are malfunctioning in ALS. Scientists can use stem cells to protect surviving nerve cells in ALS patients and prevent further degeneration.
Read More